Share price
₹154.87 latest close · +19.3% over the last 90 sessions
52-week range ₹98.36 to ₹209.80 · 1-year volatility 33.9%
How rough has the ride been?
Drawdown from peak
Largest drawdowns
-20.5% (2026-10 peak to 2026-11 low, not yet recovered)
Most recent volume spikes
2026-10-07: 6x the 50-day median, price -3.4% that day
2026-10-06: 5.6x the 50-day median, price +1.7% that day
2026-10-05: 13.4x the 50-day median, price -2.0% that day
Where does it rank among Health Services peers?
Each cell is the company's percentile rank among its Health Services peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE40th
- Op. margin59th
- Debt/equity ↓82nd
- Cash cycle ↓11th
- P/E ↓28th
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Health Services sector page Watch it move against Health Services in the Observatory
What is the price implying?
At a P/E of 166.9x, the price would imply about 42.5%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.
Fewer than six years of annual earnings are available, which is too little to measure delivered growth.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Health Services The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹154.87
- P/E
- 72.4x
- ROCE
- 14.0%
- Market Cap
- ₹1224 cr
- Revenue (TTM)
- ₹101 cr
- P/S
- 12.1x
- P/B
- 4.8x
- ROE
- 6.7%
- Operating Margin
- 24.4%
- Debt / Equity
- 0.1x
- Promoter Holding
- 71.5%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance7%Within range
Other income as a share of pre-tax profit (trailing twelve months): 7.5%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate25%Within range
Median quarterly effective tax rate over about 2.5 years: 25.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.
Cash conversion0.38xBeyond threshold
Operating cash flow divided by net profit over the last three fiscal years: 0.38x (cash from operations ₹11 cr, net profit ₹29 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.
Free cash flow1 of 4 yrsBeyond threshold
Fiscal years with positive free cash flow in the last 4: 1. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history—Not enough data
Not enough reported data to compute this.
Capital work in progress0% of fixed assetsWithin range
Capital work-in-progress is 0% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days—Not enough data
Not enough reported data to compute this.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
What changed?
6 events since Apr '26
- OctPriceVolume reached 91.5x its 50-day median on 2026-10-01; price +8.5% that day.
- SepPeer rankMoved into the 2nd quartile of Health Services on operating margin (from the 3rd quartile).
- AugPriceVolume reached 18.1x its 50-day median on 2026-08-17; price +10.9% that day.
- JunInstitutionsFII + DII holding fell 6.7 pts over 1 quarter to 5.4%.
- JunPeer rankSlipped to the 3rd quartile of Health Services on ROCE (from the top quartile).
- AprPriceVolume reached 10.6x its 50-day median on 2026-04-29; price +3.7% that day.
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history12 months · 2025-12 to 2026-11
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-11 | 72.4x | ₹101 cr | 6.7% | 14.0% | 0.1x |
| 2026-10 | 76.3x | ₹101 cr | 6.6% | 14.0% | 0.1x |
| 2026-09 | 83.7x | ₹101 cr | 6.6% | 14.0% | 0.1x |
| 2026-08 | 67.9x | ₹82 cr | 6.6% | 14.0% | 0.1x |
| 2026-07 | 54.6x | ₹82 cr | 6.6% | 14.0% | 0.1x |
| 2026-06 | 55.5x | ₹82 cr | 6.6% | 14.0% | 0.1x |
| 2026-05 | 71.6x | ₹61 cr | 51.2% | 52.0% | 0.3x |
| 2026-04 | 65.2x | ₹61 cr | 51.2% | 52.0% | 0.3x |
| 2026-03 | 52.8x | ₹61 cr | 51.2% | 52.0% | 0.3x |
| 2026-02 | 57.2x | ₹50 cr | 46.7% | 52.0% | 0.3x |
| 2026-01 | 52.8x | ₹50 cr | 46.7% | 52.0% | 0.3x |
| 2025-12 | 51.7x | ₹50 cr | 46.7% | 52.0% | 0.3x |